1. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412.
2. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84: 1831-1851.
3. The Antiarrhythmic Drugs Guideline Committee. The Guidelines for the use of antiarrhythmic drugs: Commentary on the CD-ROM version of the Guidelines and concept of the Sicilian Gambit. Tokyo: Lifemedicom Co., ltd. 2000 (in Japanese).
4. Guidelines for the Diagnosis and Treatment of Cardiovascular Diseases (1999-2000 JCS Joint Working Groups Report). Guidelines for Pharmacotherapy of Atrial Fibrillation. Jpn Circ J 2001; 65(Suppl V): 931-978 (in Japanese).
5. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). Circulation 2001; 104: 2118-2150.